Paris, France

Irina Apostolov

This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur, National Institute of Health and Medical Research. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irina Apostolov. Retrieved from https://idiyas.com/inventor/irina-apostolov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irina Apostolov: Innovator in Immunology

Introduction

Irina Apostolov is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the activation of NKT cells. Her innovative work has the potential to impact treatments for diseases requiring a granulomatous type of immune response.

Latest Patents

Irina holds a patent for a method that activates NKT cells using PIMs. The invention involves a pharmaceutical composition that includes at least a PIM-activated NKT cell. This composition can be utilized for treating diseases where a granulomatous immune response is desired. She has been granted 1 patent for this groundbreaking work.

Career Highlights

Throughout her career, Irina has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Institut Pasteur. Her experience in these organizations has allowed her to collaborate with leading experts in the field of medical research.

Collaborations

Irina has collaborated with notable colleagues, including Gabriel Gachelin and Philippe Kourilsky. These partnerships have further enriched her research and contributed to her innovative approaches in immunology.

Conclusion

Irina Apostolov is a trailblazer in the field of immunology, with her patent for activating NKT cells showcasing her innovative spirit. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…